NEW YORK – A prospective multi-omic study of irritable bowel syndrome (IBS) that encompassed a broad range of analyses and sample types has uncovered metabolic pathway shifts that appear to line up with the disease and its symptoms.
NEW YORK – A prospective multi-omic study of irritable bowel syndrome (IBS) that encompassed a broad range of analyses and sample types has uncovered metabolic pathway shifts that appear to line up with the disease and its symptoms.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.